Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
about
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.Biomechanics of haemostasis and thrombosis in health and disease: from the macro- to molecular scaleRecombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial.Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h.Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.
P2860
Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Factor VIIa analog has marked ...... om patients with hemophilia A.
@en
Factor VIIa analog has marked ...... om patients with hemophilia A.
@nl
type
label
Factor VIIa analog has marked ...... om patients with hemophilia A.
@en
Factor VIIa analog has marked ...... om patients with hemophilia A.
@nl
prefLabel
Factor VIIa analog has marked ...... om patients with hemophilia A.
@en
Factor VIIa analog has marked ...... om patients with hemophilia A.
@nl
P2093
P1476
Factor VIIa analog has marked ...... om patients with hemophilia A.
@en
P2093
Donald F Brophy
Erika J Martin
J Christian Barrett
Janice G Kuhn
Melinda E Nolte
Mirella Ezban
P304
P356
10.1097/MBC.0B013E32833B63E9
P577
2010-09-01T00:00:00Z